BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24446156)

  • 1. miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis.
    Stokowy T; Wojtaś B; Fujarewicz K; Jarząb B; Eszlinger M; Paschke R
    Horm Metab Res; 2014 Mar; 46(3):171-80. PubMed ID: 24446156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.
    Stokowy T; Wojtaś B; Krajewska J; Stobiecka E; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Jarząb B; Krohn K; Paschke R; Eszlinger M
    Mol Cell Endocrinol; 2015 Jan; 399():43-9. PubMed ID: 25258301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
    Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
    J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
    Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.
    Borrelli N; Denaro M; Ugolini C; Poma AM; Miccoli M; Vitti P; Miccoli P; Basolo F
    Mod Pathol; 2017 Jan; 30(1):39-51. PubMed ID: 27586203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
    Macerola E; Poma AM; Vignali P; Proietti A; Torregrossa L; Ugolini C; Basolo A; Matrone A; Elisei R; Santini F; Basolo F
    J Endocrinol Invest; 2023 Aug; 46(8):1651-1662. PubMed ID: 36749451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
    Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
    J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
    Wojtas B; Ferraz C; Stokowy T; Hauptmann S; Lange D; Dralle H; Musholt T; Jarzab B; Paschke R; Eszlinger M
    Mol Cell Endocrinol; 2014 May; 388(1-2):1-9. PubMed ID: 24631480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
    Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis options for high-throughput sequencing in miRNA expression profiling.
    Stokowy T; Eszlinger M; Świerniak M; Fujarewicz K; Jarząb B; Paschke R; Krohn K
    BMC Res Notes; 2014 Mar; 7():144. PubMed ID: 24625073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
    Eszlinger M; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.